Similar articles

• Septo-hippocampal system: target for substituted benzamides.

  Bischoff S, Bittiger H, Delini-Stula A, Ortmann R. Bischoff S, et al. Eur J Pharmacol. 1982 Apr 23;79(3-4):225-32. doi: 10.1016/0014-2999(82)90628-8. Eur J Pharmacol. 1982. PMID: 7201401
• Substituted benzamides as cerebral dopamine antagonists in rodents.

  Elliott PN, Jenner P, Huizing G, Marsden CD, Miller R. Elliott PN, et al. Neuropharmacology. 1977 May;16(5):333-42. doi: 10.1016/0028-3908(77)90070-3. Neuropharmacology. 1977. PMID: 559256 No abstract available.
• Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.

  Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L. Ogren SO, et al. Eur J Pharmacol. 1984 Jul 20;102(3-4):459-74. doi: 10.1016/0014-2999(84)90567-3. Eur J Pharmacol. 1984. PMID: 6149133
• Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.

  Jenner P, Marsden CD. Jenner P, et al. Acta Psychiatr Scand Suppl. 1984;311:109-23. doi: 10.1111/j.1600-0447.1984.tb06863.x. Acta Psychiatr Scand Suppl. 1984. PMID: 6142587 Review.
• Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.

  Cools AR, van Rossum JM. Cools AR, et al. Life Sci. 1980 Oct 6;27(14):1237-53. doi: 10.1016/0024-3205(80)90217-9. Life Sci. 1980. PMID: 6255271 Review. No abstract available.